Inflammation is regulated by the expression of mediators that cause a numbe
r of pleiotropic events culminating In the recruitment of inflammatory cell
s and release of biologic mediators by leukocytes. If the inflammation is t
ransient in nature, it can protect the host by activating defense mechanism
s and initiating wound repair. However, if the inflammation is inappropriat
e, it can lead to considerable tissue damage. My colleagues and I have inve
stigated the role of chemokines, particularly monocyte chemoattractant prot
ein I, in various pathological processes and the role of the proinflammator
y cytokines interleukin-1 (IL-1) and tumor necrosis factor (TNF) in experim
ental periodontitis. I will discuss first the studies on chemokines and the
n the use of IL-1 and TNF blockers in inhibiting inflammation and bone loss
in the periodontium.